Macro­Gen­ics sells rights to breast can­cer drug; Rice’s new biotech ac­cel­er­a­tor

Plus, news about An­nex­on, Passkey Ther­a­peu­tics, XO­MA Roy­al­ty and Twist Bio­science:

Macro­Gen­ics sells breast can­cer drug rights for up to $75 mil­lion: The com­pa­ny is …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER